Business

€56 Bln Bayer Eyes Pharmaceutical Manufacturing in Ethiopia

BirrMetrics · last week · Read the Full Story on BirrMetrics
€56 Bln Bayer Eyes Pharmaceutical Manufacturing in Ethiopia
AI SUMMARY

German health giant Bayer AG is exploring local pharmaceutical manufacturing in Ethiopia following a memorandum of understanding signed with the Ministry of Health in December 2025.

  • German healthcare multinational Bayer AG is exploring local manufacturing operations in Ethiopia to expand access to essential medicines and maternal healthcare.
  • The initiative follows a memorandum of understanding signed between Bayer and the Ethiopian Ministry of Health in December 2025.
  • Bayer CEO Bill Anderson held discussions with Finance Minister Ahmed Shide in October 2025 regarding local pharmaceutical production.
  • Priority areas of cooperation include pharmaceutical supply chains, maternal and child nutrition, reproductive healthcare, and non-communicable diseases.
  • Neither Bayer nor the Ministry has disclosed investment amounts, facility locations, production capacity, or operational timetables.
  • Bayer reported 45.58 billion euros in revenue and a net loss of 3.62 billion euros for the 2025 financial year.
  • Health Minister Dr. Mekdes Daba reported in August 2026 that domestic market share of locally manufactured medicines rose from 8 percent to 44 percent.
  • Ethiopia's pharmaceutical sector strategy features the Kilinto manufacturing zone in Addis Ababa and aims to reach a 4 billion US dollar market by 2030.